Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 91 - 120 of 368
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Technescan Sestamibi valmisteyhdistelmä radioaktiivista lääkettä varten, SPC 2022-04-06
		European Medicines Agency's website: Tecovirimat SIGA - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: TECVAYLI - EMA: EPAR PI Finnish Swedish
PL	Resepti	Teglutik 5 mg-ml oraalisuspensio SPC 2023-01-16
PL	Resepti	Tegretol 100 mg, 200 mg tabletti, 20 mg-ml oraalisuspensio, Tegretol Retard 200 mg, 400 mg depottabletti SPC 2023-07-10
PL	Resepti	Tegretol 100 mg, 200 mg tabletti, 20 mg-ml oraalisuspensio, Tegretol Retard 200 mg, 400 mg depottabletti SPC 2024-09-24
PL	Resepti	Tegretol 100 mg, 200 mg tabletti, 20 mg-ml oraalisuspensio, Tegretol Retard 200 mg, 400 mg depottabletti SPC 2024-09-24
		European Medicines Agency's website: Tegsedi - EMA: EPAR PI Finnish Swedish
PL	Resepti	Tekcis 2-50 GBq radionuklidigeneraattori, SPC 2023-12-29
PL	Resepti	Tektrotyd 20 mikrog valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2023-11-10
PL	Resepti/itsehoito	Telfast 120 mg tabletti, kalvopäällysteinen SPC 2023-10-03
PL	Resepti	Telfast 30 mg tabletti, kalvopäällysteinen SPC 2023-07-15
PL	Resepti	Telmark 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2022-02-03
		European Medicines Agency's website: Telmisartan Actavis - EMA: EPAR PI Finnish Swedish
PL	Resepti	Telmisartan Orion 40 mg, 80 mg tabletti SPC 2023-08-30
PL	Resepti	Telmisartan Ratiopharm 40 mg, 80 mg tabletti SPC 2021-06-17
PL	Resepti	Telmisartan Sandoz 40 mg tabletti SPC 2021-08-06
PL	Resepti	Telmisartan Stada 20 mg, 40 mg, 80 mg tabletti, kalvopäällysteinen SPC 2021-09-07
PL	Resepti	Telmisartan-Hydrochlorothiazide Accord 40 mg - 12,5 mg, 80 mg - 12,5 mg, 80 mg - 25 mg tabletti SPC 2023-02-03
PL	Resepti	Telmisartan-Hydrochlorothiazide Orion 40 mg-12.5 mg tabletti SPC 2024-07-22
PL	Resepti	Telmisartan-Hydrochlorothiazide Orion 80 mg-12.5 mg tabletti SPC 2024-07-22
PL	Resepti	Telmisartan-Hydrochlorothiazide Orion 80 mg-25 mg tabletti SPC 2024-07-22
		European Medicines Agency's website: Telzir - EMA: EPAR PI Finnish Swedish
PL	Resepti	Temesta 1 mg tabletti SPC 2023-03-16
PL	Resepti	Temgesic 0.2 mg, 0.4 mg resoribletti SPC 2024-08-22
PL	Resepti	Temgesic 0.3 mg-ml injektioneste, liuos SPC 2024-08-22
		European Medicines Agency's website: Temodal - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Temomedac - EMA: EPAR PI Finnish Swedish
PL	Resepti	Temozolomid ratiopharm 20 mg, 100 mg, 140 mg, 180 mg ja 250 mg kapseli, kova SPC 2022-01-18
		European Medicines Agency's website: Temozolomide Accord - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >